Skip to Content

Tools

Activity

Activity Description

The committee will review the epidemiological, clinical, and biological evidence regarding adverse health events associated with specific vaccines covered by the Vaccine Injury Compensation Program. The vaccines to be reviewed are varicella zoster vaccine, influenza vaccines, hepatitis B vaccine, and human papillomavirus vaccine. Other vaccines could be added if additional funding is secured. The committee will author a consensus report with conclusions on the evidence bearing on causality and the evidence regarding the biological mechanisms that underlie specific theories for how a specific vaccine is related to a specific adverse event. The project is sponsored by the U.S. Department of Health and Human Services. The approximate start date for the project is 25 September 2008. A report will be issued at the end of the project.

Public Comment: If you have information you would like to share with the committee, you can do so by submitting your comment to the project e-mail at vaccinesafety@nas.edu.

Any comment you submit to the committee, including your name and identifying information will not be kept confidential and will be included in the Public Access File as the National Academy of Sciences complies with Section 15 of the Federal Advisory Committee Act (FACA). The National Academies shall be authorized to use any such comments or submissions in accordance with the National Academies’ Terms of Use Statement<.>

The project staff will use the vaccine safety mailing list to share information on activities of the Committee to Review Adverse Effects of Vaccines. The listserv will send one to three announcements per month about committee activities for the duration of the project.

If you would like to receive these e-mails, please click here to subscribe to the vaccine safety listserv.

If you have subscribed and wish to remove yourself from the vaccine safety listserv, please click here to unsubscribe

For more information

Stay up to date!

Study Staff

Other Activity Resources

Activity Contact Information

For More Information Contact

Board on Population Health and Public Health Practice
Phone:
202-334-2077
Fax:
202-334-2939
E-mail:
vaccinesafety@nas.edu

Mailing Address


Keck Center
500 Fifth St. NW
Washington, DC 20001